A Zambian acquaintance here at the HIV R4P conference in Cape Town shared the news this morning that the country’s President, Michael Sata, has died. “It is too much,” she said, noting he is the second president to die in office in six years, and in the short history of the country that just celebrated […]
First came RV144, the clinical HIV vaccine trial in Thailand that became the first such trial to end in modest success, with a candidate that offered some protection against the virus. That was big news, although among the work ahead that it pointed to — in addition to seeing if it could offer stronger and […]
BARCELONA, Spain – The opening press conference of the 45th Union World Conference on Lung Health highlighted a new report calling for international action against the latest co-epidemic, tuberculosis and diabetes. With alarming similarities to the deadly synergy of HIV/TB, the intersection between tuberculosis and diabetes compromises treatment outcomes for both diseases, Dr. Anthony Harries told a packed […]
HIV
The following is a guest post by Mitchell Warren of AVAC This year’s annual HIV Vaccine Awareness Day arrives Saturday at a promising and also perilous […]
Tuberculosis
In sub-Saharan Africa where the odds of dying within a year of starting treatment for HIV can still hover close to one-in-10, diagnosing and treating TB […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in […]